D46.9

Billable

Myelodysplastic syndrome, unspecified

HCC Category Mapping

V28HCC 19 — Lymphoma and Other Cancers

0.105

V24HCC 46 — Severe Hematological Disorders

0.666

ESRDHCC 46 — Severe Hematological Disorders

0.000

RxHCCHCC 19 — Lymphoma and Other Cancers

0.000

What This Code Means

A bone marrow disorder where blood cells cannot be produced normally, but the specific type or subtype cannot be determined.

Coding Tips

•This is a catch-all code for myelodysplastic syndromes when subtype is not specified
•Always attempt to identify the specific MDS subtype (D46.0-D46.A) for more accurate coding

Clinical Significance

Myelodysplastic syndrome, unspecified, is a bone marrow failure disorder characterized by ineffective hematopoiesis, peripheral cytopenias, and risk of transformation to acute myeloid leukemia. This unspecified code indicates that the specific World Health Organization subtype has not been established, which limits prognostic stratification and treatment planning.

Documentation Requirements

✓Use this code when myelodysplastic syndrome is diagnosed but the specific subtype is not documented.
✓A provider query should be initiated for bone marrow biopsy results, cytogenetic analysis, and blast percentage to enable more specific coding.
✓Document peripheral blood counts, transfusion dependence, and any infections or bleeding complications.

Commonly Confused Codes

D46.0 through D46.C are specific myelodysplastic syndrome subtypes and should be used when documentation permits.D75.89 (other specified diseases of blood) may be used for other hematologic conditions.C92.00 (acute myeloblastic leukemia) is used when myelodysplastic syndrome has transformed with 20% or more blasts.D47.1 (chronic myeloproliferative disease) is a related but distinct entity.